Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure

Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure

Bibliographic Details
Main Authors:	Nestor Oliva‐Damaso, Julio Nuñez, Maria Jose Soler
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	biomarkers diuretic response heart failure urine sodium
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.123.030044

Similar Items

The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century
by: Alberto Palazzuoli, et al.
Published: (2024-03-01)

The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study
by: Andrew Xanthopoulos, et al.
Published: (2023-03-01)

Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
by: Norbert Lameire
Published: (2023-01-01)

Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure
by: Belén García-Magallón, et al.
Published: (2022-05-01)

Ultrafiltration versus Diuretics on Prognostic Cardiac and Renal Biomarkers in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
by: Kirsty Luo-Yng Tay, et al.
Published: (2023-04-01)

Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01)

Could admission level of uric acid predict total diuretic dose in acute heart failure?
by: Maryam Chenaghlou, et al.
Published: (2024-01-01)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
by: Alberto Palazzuoli, et al.
Published: (2021-09-01)

European Consensus on use of diuretics in chronic heart failure 2019
by: M. V. Leonova
Published: (2020-05-01)

Clinical phenotypes according to diuretic combination in acute heart failure
by: Raquel López-Vilella, et al.
Published: (2023-09-01)

Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretic Resistance
by: Jorge Fernandes, et al.
Published: (2023-02-01)

Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2‐year experience
by: Eric Wierda, et al.
Published: (2023-02-01)

The Effect of Early Diuretic Treatment on Clinical Outcomes in Patients with Acute Heart Failure: Door to Diuretic
by: Abuzer Özkan, et al.
Published: (2023-09-01)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
by: Ákos Géza Pethő, et al.
Published: (2023-06-01)

The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure
by: Panagiotis Stachteas, et al.
Published: (2024-03-01)

HEART FAILURE PATIENTS ARE PRONE TO DEVELOP MAGNESIUM DEFIECIENCY AS A RESULT OF DIURETIC / DIGOXIN THERAPY
by: Surraiya Shaikh, et al.
Published: (2008-01-01)

HEART FAILURE PATIENTS ARE PRONE TO DEVELOP MAGNESIUM DEFIECIENCY AS A RESULT OF DIURETIC / DIGOXIN THERAPY
by: Surraiya Shaikh, et al.
Published: (2008-01-01)

Use of short‐acting vs. long‐acting loop diuretics after heart failure hospitalization
by: Shohei Imaeda, et al.
Published: (2022-10-01)

Association between changes in loop diuretic dose and outcomes in acute heart failure
by: Yuta Seko, et al.
Published: (2023-06-01)

Diuretic resistance and the role of albumin in congestive heart failure
by: Carol Fernandez Hazim, et al.
Published: (2023-12-01)

SAFETY OF DIURETIC ADMINISTRATION IN EARLY DYSPNEA PATIENTS NOT FINALLY DIAGNOSED WITH ACUTE HEART FAILURE: A CLINICAL STUDY.
by: Saubhagya Chhotaray, et al.
Published: (2023-12-01)

Evaluation of sodium‐glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics
by: Yi‐Fang Weng, et al.
Published: (2023-04-01)

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study
by: Abdulaziz Alsalem, et al.
Published: (2024-04-01)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
by: Mauro Feola, et al.
Published: (2020-09-01)

Diuretic Resistance Prediction and Risk Factor Analysis of Patients with Heart Failure During Hospitalization
by: Xiao Lu, et al.
Published: (2022-05-01)

Impact of loop diuretic dosage in a population of patients with acute heart failure: a retrospective analysis
by: P. Meani, et al.
Published: (2023-11-01)

Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation
by: Guillaume Baudry, et al.
Published: (2023-10-01)

A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
by: Ram Gelman, et al.
Published: (2023-05-01)

IGFBP7 is a predictor of diuretic-induced acute kidney injury in the patients with acute decompensated heart failure
by: Görgülü Sinan, et al.
Published: (2022-08-01)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
by: Daniela Tomasoni, et al.
Published: (2022-06-01)

CIRCADIAN BLOOD PRESSURE PROFILE AND DIFFERENT DIURETIC THERAPY REGIMENS IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE: EFFECTS ON NATRIURETIC PEPTIDE LEVELS
by: M. A. Bortsova, et al.
Published: (2009-06-01)

Preliminary Report of Intravenous Tolvaptan Sodium Phosphate (Samtas<sup>®</sup>) Treatment in Decompensated Heart Failure
by: Makiko Nakamura, et al.
Published: (2024-01-01)

Association between loop diuretic dose administered in first 24 hours of heart failure admissions and length of hospital stay
by: Ahmad Ramy Elashery, et al.
Published: (2018-07-01)

Association between sodium-to-potassium ratio in spot urine and hospitalization due to heart failure in high-risk Japanese patients
by: Tsuneaki Sadanaga, et al.
Published: (2024-02-01)

Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting
by: A I Ponomareva, et al.
Published: (2014-09-01)

All diuretics used in the treatment of hypertension are not the same
by: Serkan Asil, et al.
Published: (2017-01-01)

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study
by: Masami Nishino, et al.
Published: (2022-02-01)

Effects of Three Commonly-used Diuretics on the Urinary Proteome
by: Xundou Li, et al.
Published: (2014-06-01)

The Effects of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Results from the EPICC Randomized Controlled Trial
by: Juan Torres-Macho, et al.
Published: (2022-08-01)

Sodium Intake and Heart Failure
by: Yash Patel, et al.
Published: (2020-12-01)